ArticleMolecules (Basel, Switzerland)2022

DUSP4 Silencing Enhances the Sensitivity of Breast Cancer Cells to Doxorubicin through the Activation of the JNK/c-Jun Signalling Pathway.

Mashael S Al-Mutairi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.